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Abstract
Background: Two thirds of all falciparum malaria cases reported in the United Kingdom (UK) are
acquired in West Africa (WA). To ensure recommendations and guidelines for malaria prophylaxis
in travellers to West Africa correlate to the risk of infection, a study was undertaken to examine
recent trends and predict future patterns of imported malaria acquired by UK residents visiting
West Africa and West African visitors to the UK between 1993 and 2006.
Methods and Results: Using passenger numbers and malaria surveillance reports, the data
revealed a 2.3-fold increase in travel to West Africa with a five-fold increase in travelers visiting
friends and relatives (VFR). Malaria incidence fell through the study period, the greatest decline
noted in VFR with a fall from 196 cases/1,000 person-years to 52 cases/1,000 person-years, 9.8%
per year p < 0.0001. The risk for travellers from the UK visiting for other reasons declined 2.7 fold,
at an annual decrease of 7.0%, with the incidence in West African visitors to the UK falling by 2.3
fold, a rate of 7.9% annually.
Discussion: The reduction in incidence among all three groups of travellers may be explained by
several factors; changing chemoprophylaxis usage and/or increased travel in urban areas where
malaria risk has declined over the past decade, or widespread reduction in malaria transmission in
West Africa.
Conclusion: With the reduction in malaria incidence seen in both visitors to and from West
Africa, the most rational explanation for these findings is a fall in malaria transmission in West
Africa, which may require a change in chemoprophylaxis policy for UK travelers over the next 5–
10 years.
Background
Malaria remains a threat to travellers visiting endemic
regions. Since 1987, approximately 39,000 cases of
malaria have been reported to the UK reference laboratory
[1]. A number of risk factors for acquiring malaria during
travel have been identified, of which destination is the
most important. West Africa accounts for approximately
two thirds of all cases reported in the UK, with travellers
to Nigeria and Ghana making up half of all imported Plas-
modium falciparum infections [2,1]. The reason for travel is
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another significant contributory factor and three quarters
of all reported cases occur in travellers who have been vis-
iting friends and relatives (VFR)[3,1,4] in West Africa.
Failure to take or comply with the correct chemoprophy-
lactic regimens is associated with higher rates of malaria.
Unsurprisingly, only 42% of malaria cases report the use
of any prophylaxis, and under 10% of VFR cases have used
a correct prophylactic regimen [1]. Duration of visit may
also be important, with longer exposure presumably
increasing the risk of malaria [5].
The current study was designed to inform and estimate the
impact of the UK's malaria prevention policy by estimat-
ing the changing trend of malaria in travellers to West
Africa, and the contribution of known risk factors to mor-
bidity. Malaria incidence in travellers to and from the
region has not been examined since 1987 [4].
Methods
Data collection
Travel by UK residents to malaria endemic countries
Data on overseas travel by UK residents were obtained
from the Office for National Statistics (ONS), collected as
part of the International Passenger Survey (IPS). The IPS is
a year round survey of incoming and outgoing passengers
at all major ports as part of the government's data collec-
tion for its balance of payments account. Around 250,000
face-to-face interviews of a randomly selected sample of
passengers (representing 0.2% of all travellers) provide
estimates of the total annual overseas visits made by UK
residents, and the number of incoming visits to the UK
from other countries. The survey design and passenger
flows are used to calculate weights and hence sampling
errors [6]. The survey also collects information on the rea-
son for and duration of travel. The units are numbers of
visits made, rather than individuals travelling, many of
whom may make repeated trips. The study countries were
Sierra Leone, Nigeria, Ghana and The Gambia, since these
are the most popular destinations in the region for UK res-
idents. For other West African countries, the sample size
was too small to assess the denominator accurately. The
data were stratified by reason for travel into two major
groups: UK residents travelling to visit friends and rela-
tives (VFR) and UK residents travelling for all other pur-
poses such as business, vacation, study and the military
(non-VFR). The number of residents from the study
region arriving in the UK (overseas visitors) were collected
through the same survey and used to estimate the inci-
dence of malaria occurring in visitors to the UK.
Surveillance data on malaria
Malaria surveillance reports were provided by the Malaria
Reference Laboratory (MRL) of the Health Protection
Agency (HPA). The MRL, as the national reference labora-
tory, obtains enhanced passive surveillance reports of
malaria cases through laboratories and clinicians who are
asked to provide details of the patient's age, destinations,
duration and reason for the journey and use of chemo-
prophylaxis. The ascertainment process has been
described previously and has remained unchanged over
the current study period [1]. Cases were included if Sierra
Leone, Nigeria, Ghana or The Gambia was said to have
been visited before the onset of laboratory confirmed
malaria. Malaria cases were excluded if there was incom-
plete information on destination or purpose of travel.
Twenty nine percent of all MRL reports had missing data
on reason for travel and 12% had incomplete data on the
country visited [1].
Statistical methods
The risk of malaria was estimated as the incidence rate per
1,000 person-years exposed. The numerator was the
number of cases reported each year to the MRL, and the
denominator was the estimated time spent in West Africa,
from the IPS survey. Trend analysis was done by regres-
sion of the logarithms of the incidence rates [7]. Weights
were set equal to the reciprocals of the sampling variances,
which were estimated as the sum of sampling variances of
the log-numerator and log-denominator. The former was
estimated via the Poisson distribution as the reciprocal of
the number of cases, and the latter from the 95% confi-
dence intervals provided by the ONS. Finally, to allow for
possible autocorrelation over time, the effective sample
size was estimated from the regression residuals [8]. The
effective sample size, which is less than or equal to the
actual sample size, was used to determine the degrees of
freedom for the regression analysis, which was done using
the statistical package R (R Development Core Team,
2007).
Results
Trends in travel to West Africa
Visits by UK residents to West Africa more than doubled
from 91 to 206 thousand between 1993 and 2006, an
increase of 2.3-fold, or 9% per year (95% confidence
interval (CI) 4.7–13%). VFR increased more than five-fold
from 23 to 117 thousand, 15% per year (95% CI, 12–
17%). Travel by non-VFR has risen by a third, from 68 to
89 thousand between 1993 and 2006, an increase of 4%
per year (95% CI 0.5 – 8%). Since 2001, travel by VFR has
been the predominant reason for visiting West Africa,
with their proportion of total visits increasing from 25%
in 1993 to 57% in 2006.
Trends in travel from West Africa to the UK
The number of arrivals into the UK by West African resi-
dents increased from 101 to 180 thousand between 1993
and 2006, an increase of 6% per year (95% CI 3.4 –
8.7%). Most of the arrivals were from Nigeria with just
over 128,000 arrivals from this country in 2006 (Figure
1).Malaria Journal 2008, 7:235 http://www.malariajournal.com/content/7/1/235
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Imported malaria
Of the total 8,273 malaria reports in travellers to and from
West Africa during the study period, 6,655 (80%) were in
UK residents visiting the region. Malaria reports per year
increased by 5% from 463 in 1993 to 486 in 2006.
Imported malaria cases from West Africa among VFR rose
by 15% from 364 to 418 in 2006, while the number of
cases in non-VFR fell by a third from 99 to 68 cases. 85%
(5,676) of the malaria cases in UK residents from West
Africa originated from two countries (Nigeria and
Ghana), with most cases (3,820) from Nigeria, 3,402 of
these cases were in VFR.
Malaria cases in foreign visitors arriving in the UK
Of all the malaria cases occurring in visitors to the UK, one
fifth (1,618 cases) were in West African residents arriving
in the UK between 1993 and 2006 (range 90–154 annu-
ally). Residents arriving from Nigeria accounted for 60%
(968) of all cases from the region.
Malaria incidence rates
Linking the number of cases of malaria with the increasing
time spent in West Africa shows decreasing trends in inci-
dence rates (Figure 2). Malaria incidence in VFR reduced
by a factor of 3.7 from 196 cases/1,000 person-years in
1993 to 52 cases/1,000 person-years in 2006, correspond-
ing to an average reduction of 9.8% per year (95% CI 6.5–
13%, p < 0.0001). For non-VFR the decrease was 7.0% per
year (95% CI 0.4–13, p = 0.04) and for residents of West
Africa it was 7.9% per year (95% CI 5.6–10%, p < 0.0001).
The non-VFR trend showed an unpredicted peak in 2000.
This was the result of an increase in malaria cases occur-
ring in tourists visiting The Gambia which apparently
resulted from a weather anomaly between November and
December 2000 [9].
Discussion
This study has been possible because of the near unique
denominator data collected through the International
Passenger Survey which provides number of visits, reason
for travel and duration of stay by UK residents by country.
The IPS data, therefore, allows the calculation of rates of
malaria infection over time [10]. These data have been
validated against arrival statistics produced by the World
Tourism Organization (WTO) [10]. Malaria notifications
to the surveillance body remain considerably under-
reported [11,12] and do not capture travellers who are ill
abroad. However, there has been no change in reporting
methodology over the study period so factors such as data
quality and misclassification [13], which could affect
absolute rates, would not be expected to influence the
trend.
The 2.3 fold increase in travel to West Africa, and the
increasing proportion of VFR, contrasts with the decade
1977–1986, when the biggest increase was due to tourism
to The Gambia (528%) while all travel to Nigeria and
Ghana increased by only 4% and 70% respectively [10].
Despite travel doubling over the study period, there has
been almost no increase (5%) in the number of imported
malaria cases. Non-VFR travellers' cases fell by a third,
with VFR showing a 15% increase. Most of the malaria
originated from Nigeria and Ghana, and 86% of cases
were in VFR. Malaria from the Gambia is in non-VFR and
remained static at around 28 cases annually until an out-
break occurred 1998–2001. The numbers of annual visits
to The Gambia over this period also remained static at
37,400–40,000 per year [9]. One can only speculate what
factors have led to this increase in travel to Ghana and
Nigeria. The annual migration from these two countries to
the UK since 1991 has doubled the numbers of settled
migrants living in the UK [14,15] This expanded popula-
tion would explain the increased travel by VFR to West
Africa.
The proportion of UK VFR travellers to West Africa who
contracted malaria was 0.5% [10] in 1986 and 1% in
1987, while in tourist and business travellers malaria
occurred in 0.2% of visits in 1987 [4]. Since 1987, cases
imported into the UK from all countries have remained
relatively static [1], but West Africa has provided around
two thirds of all falciparum malaria cases. A decline in
malaria in UK travellers was first reported in 1990, where
an unexplained 37% decrease in imported malaria in
tourists visiting Kenya was reported [16].
Trends of imported malaria in Swedish travellers between
1997 and 2003 were studied using surveillance reports
and a telephone sample survey of recent travel. Their over-
all rate of imported malaria from West Africa was esti-
mated to be 30 cases per 10,000 travellers, with the risk
from East African travel being less [17]. The risk of malaria
from East, West and Central Africa ranged between 0.24%
to 0.36% per visit. These were similar proportions to those
in UK residents visiting sub-Saharan Africa over the same
period: 0.14%–0.26%. The Swedish study could not sepa-
rately identify VFR but the authors suggest they are a high
risk group.
There are a number of factors which may have contributed
to the falling incidence of malaria. The most obvious
would be wider uptake of malaria chemoprophylaxis in
travellers but the reverse has been reported. Studies in the
late 1980s and 1990s estimated the proportion of VFR
using chemoprophylaxis to be 46% [4]. A more recent
analysis by Smith et al of malaria cases imported between
1999 and 2006 revealed that a mere 7% of VFR and 24%
of non-VFR from sub-Saharan Africa used a recommended
chemoprophylactic agent [1]. Krause reported that the
proportion of malaria cases in Germany using any proph-
ylaxis fell from 58% to less than 40% over the same periodMalaria Journal 2008, 7:235 http://www.malariajournal.com/content/7/1/235
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Annual increase in visits made by the three groups of travellers to and from West Africa between 1993 and 2006 Figure 1
Annual increase in visits made by the three groups of travellers to and from West Africa between 1993 and 
2006. Graphs show trend plot, mean and 95% CI. The top graph is UK residents visiting friends and relatives in West Africa, 
the middle graph is UK residents visiting West Africa for other reasons, the bottom graph is West African residents visiting the 
UK.
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Change in annual incidence of malaria in the three groups of travellers, graphs show trend plot, mean and 95% CI Figure 2
Change in annual incidence of malaria in the three groups of travellers, graphs show trend plot, mean and 95% 
CI. The slopes of the 3 curves are not signifcantly different. The top graph is UK residents visiting friends and relatives in West 
Africa, the middle graph is UK residents in West Africa for other reasons, the bottom graph is West African residents visiting 
the UK.
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[18]. Nevertheless, the data are limited and some studies
suffer from possible methodological problems such as
possibly unrepresentative samples, so changes in the pro-
portion of at-risk travellers using prophylaxis cannot be
ruled out as an explanation of these findings.
Reduction in the intensity of malaria transmission in West
Africa may have contributed to the reduced incidence in
travellers. Sub-Saharan Africa has benefited from a
number of campaigns to reduce the morbidity and mor-
tality associated with the disease. The implementation of
insecticide-treated bed net programmes has reduced
malarial episodes in areas of stable malaria by half [19].
Reduction in malaria transmission in cities and urban
environments, where many VFR visit, may also be contrib-
uting to the decline in transmission of malaria. The mean
entomological inoculation rate (EIR) in urban centres
compared to the mean EIR of rural areas, are 98-fold lower
in dry savannas and Sahel regions, and 16-fold lower in
wet savannas and forest zones [20]. Significant reductions
of the burden of malaria have been reported from inter-
vention sites in East Africa [21] following long term
malaria control measures [22], including the use of artem-
isinin-based combination therapy and insecticide-treated
nets [23]. Widespread malaria control measures may be
having a similar impact on the burden of disease in trav-
ellers and West African visitors to the UK.
Accurate information on the incidence and trends of
malaria in travellers has a number of obvious benefits.
Policy for malaria prevention, especially chemoprophy-
laxis, can be more accurately targeted, when the risks are
known. [24]. The future implications of this decline,
should it continue, are that within the next 5–10 years the
incidence could reach rates similar to those seen in South
America [25] and the Indian sub-continent [24], where
the risk was estimated to be < 1 case per 1000 years
exposed and where the risk of adverse events are higher
than the risk of acquring benign malaria. The major differ-
ences between these regions is that Plasmodium falciparum
is the predominant species imported from West Africa,
whereas Plasmodium vivax predominates in travellers from
South America and the Indian sub-continent. Recommen-
dations on the use of  standby treatment might provide an
alternative strategy to chemoprophylaxis for travellers at
such low risk of falciparum malaria and is already in use
by some national bodies in low risk regions[26].
This study has been able to generate, for the first time, the
incidence of malaria per unit time exposed in UK travel-
lers to West Africa. This analysis has revealed a significant
reduction in incidence of malaria over the study period in
all groups of travellers but most notably in VFR. Although
the reduction may have several contributory factors, the
hypothesis that best links to the global reduction in inci-
dence of travel associated malaria is reduced malaria
transmission within the region. Future policy may need to
accomodate the changing risk of travel associated malaria
and develop new preventative strategies for low risk trav-
ellers.
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